Spero Therapeutics
SPRO
#8996
Rank
โ‚ฌ0.10 B
Marketcap
1,95ย โ‚ฌ
Share price
-0.87%
Change (1 day)
102.06%
Change (1 year)

EPS for Spero Therapeutics (SPRO)

EPS in 2025 (TTM): -0,73ย โ‚ฌ

According to Spero Therapeutics's latest financial reports the company's current EPS (TTM) is -0,67ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -1,08ย โ‚ฌ.

EPS history for Spero Therapeutics from 2017 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-0,73ย โ‚ฌ-32.35%
2024-1,08ย โ‚ฌ
2022-1,42ย โ‚ฌ
2020-3,08ย โ‚ฌ9.39%
2019-2,81ย โ‚ฌ25.48%
2018-2,24ย โ‚ฌ-51.35%
2017-4,61ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Franklin Covey
FC
0,21ย โ‚ฌ-131.65%๐Ÿ‡บ๐Ÿ‡ธ USA
IBM
IBM
7,26ย โ‚ฌ-1,178.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Thomson Reuters
TRI
3,32ย โ‚ฌ-592.41%๐Ÿ‡จ๐Ÿ‡ฆ Canada